About this trial
Small Incision Lenticule Extraction (SMILE) was introduced in 2011 using the VISUMAX femtosecond laser (Carl Zeiss Meditec, Jena, Germany). It is designed for correction of myopia and myopic astigmatism.
It involves the creation of a corneal tissue disk called lenticule and its extraction through a minimally invasive incision, utilizing only a femtosecond laser. This enables rapid visual recovery with very little discomfort to the patient.
This observational case series monitors visual and refractive outcomes of myopic correction for more than -7.75 D.
It is to
* gather long-term results and refractive stability * detect rare complications or side-effects * evaluate the efficacy in a large number of patients
Eligibility criteria
This trial accepts healthy volunteersQualifiers
adults
myopia more than -7.75 D
refractive stability more than 1 year
Disqualifiers
corneal irregular astigmatism
ectatic conditions
Trial population
Adult patients with myopia more than -7.75 D seeking refractive surgery
Trial design
Other
Cross-sectional
Treatments tested in this trial
Small Incision Lenticule Extraction (SMILE) with Visumax (Carl Zeiss Meditec, Jena)
Other interventionCreation of a corneal tissue disk called lenticule and extraction through a minimally invasive incision, utilizing only a femtosecond laser
Treatment groups
Trial outcomes
Primary outcomes
Subjective Distance Refraction
Subjective Refraction
Distance Visual Acuity
Visual Acuity sine and cum correctione
Secondary outcomes
Tectonic stability as assessed by Pentacam
Corneal tectonic stability post surgery as assesed by Scheimpflug-Tomography
Epithelial thickness map in Optical coherence tomography
Change of Thickness of epithelium pre and post surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Suphi Taneri
Lead sponsor
St. Franziskus Hospital
Sponsor institution